Original language | English |
---|---|
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 32 |
Issue number | 15 |
Publication status | Published - 20 May 2014 |
Event | 50th Annual Meeting of the American-Society-of-Clinical-Oncology - Chicago, Israel Duration: 30 May 2014 → 3 Jun 2014 |
Epidermal growth factor receptor copy number gain (EGFR CNG) and response to gefitinib in esophageal cancer (EC): Results of a biomarker analysis of a phase Ill trial of gefitinib versus placebo (TRANS-COG).
Russell D. Petty, Asa Dahle-Smith, Zosia Miedzybrodzka, Susan J. Dutton, Graeme I. Murray, David Stevenson, Doreen Massie, Aileen Osbourne, Caroline Clark, Wasat Mansoor, Joyce Thompson, Mark Harrison, Anirban Chatterjee, Stephen Falk, Seanmp Elyan, Angel Garcia-Alonso, David Walter Fyfe, Ian Chau, Diane Collinson, David Ferry
Research output: Contribution to journal › Abstract › peer-review